Gregg C Fonarow Selected Research

Urea (Carbamide)

12/2023	A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure.
12/2017	Contemporary Epidemiology, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results From the China Heart Failure (China-HF) Registry.
9/2012	Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
9/2010	Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure.
1/2010	A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program.
5/2008	Albumin levels predict survival in patients with systolic heart failure.
1/2008	Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.
5/2007	Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
1/2007	An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry.
6/2006	Relation of loop diuretic dose to mortality in advanced heart failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregg C Fonarow Research Topics

Disease

481	Heart Failure 05/2024 - 01/2002
119	Stroke (Strokes) 02/2024 - 05/2008
112	Atrial Fibrillation 12/2023 - 11/2007
88	Ischemic Stroke 05/2024 - 01/2009
73	Myocardial Infarction 01/2022 - 03/2002
58	Hemorrhage 12/2023 - 04/2011
38	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022 - 05/2002
37	Acute Coronary Syndrome 12/2023 - 05/2002
34	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 08/2002
31	Hypertension (High Blood Pressure) 12/2023 - 06/2002
30	Left Ventricular Dysfunction 01/2020 - 01/2003
29	ST Elevation Myocardial Infarction 04/2023 - 10/2004
24	Chronic Renal Insufficiency 01/2023 - 02/2009
20	Diabetes Mellitus 01/2021 - 01/2007
18	Systolic Heart Failure 11/2014 - 12/2006
16	Renal Insufficiency (Renal Failure) 07/2022 - 01/2006
16	Atherosclerosis 08/2014 - 08/2002
15	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2023 - 06/2012
14	Cerebral Hemorrhage 05/2024 - 10/2010
14	Cardiogenic Shock 08/2023 - 09/2005
14	Transient Ischemic Attack 01/2022 - 01/2009
13	Inflammation (Inflammations) 07/2020 - 01/2003
11	Type 2 Diabetes Mellitus (MODY) 01/2023 - 05/2009
10	Vascular Diseases (Vascular Disease) 12/2023 - 08/2002
10	Acute Kidney Injury (Acute Renal Failure) 08/2023 - 11/2013
10	Heart Arrest (Cardiac Arrest) 04/2023 - 10/2007
9	Cardiomyopathies (Cardiomyopathy) 11/2023 - 08/2008
9	COVID-19 10/2023 - 07/2020
9	Hypotension (Low Blood Pressure) 08/2023 - 12/2006
9	Obesity 01/2023 - 01/2002
9	Dyspnea (Shortness of Breath) 11/2021 - 01/2007
9	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2002
9	Thrombosis (Thrombus) 11/2019 - 11/2005
8	Anemia 10/2013 - 06/2002
7	Dyslipidemias (Dyslipidemia) 01/2023 - 03/2004
7	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 04/2015
7	Frailty 01/2022 - 07/2013
7	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020 - 01/2003
7	Hyperkalemia 12/2017 - 06/2012
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 05/2011

Drug/Important Bio-Agent (IBA)

81	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2024 - 01/2002
52	Angiotensin Receptor AntagonistsIBA 01/2024 - 01/2002
49	Mineralocorticoid Receptor AntagonistsIBA 03/2024 - 01/2002
48	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2024 - 02/2011
45	LipidsIBA 12/2023 - 01/2002
41	AnticoagulantsIBA 11/2023 - 04/2010
36	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 03/2002
36	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2009
34	SodiumIBA 04/2024 - 06/2002
33	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 01/2003
30	CreatinineIBA 04/2024 - 06/2006
26	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2022 - 01/2003
25	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2010
22	DiureticsIBA 04/2024 - 01/2002
22	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2023 - 01/2016
20	Neprilysin (Neutral Endopeptidase)IBA 03/2024 - 01/2016
20	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2024 - 09/2012
19	CholesterolIBA 01/2018 - 08/2002
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2005
15	oxidized low density lipoproteinIBA 01/2021 - 08/2002
15	Digoxin (Digitek)FDA LinkGeneric 12/2020 - 01/2012
14	Clopidogrel (Plavix)FDA Link 02/2023 - 05/2002
14	Vitamin K FDA Link 01/2023 - 05/2012
14	Hemoglobins (Hemoglobin)IBA 01/2021 - 06/2002
13	TroponinIBA 11/2023 - 01/2003
12	Natriuretic PeptidesIBA 12/2023 - 01/2002
12	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2020 - 05/2002
11	NitrogenIBA 12/2023 - 01/2006
11	Urea (Carbamide)FDA LinkGeneric 12/2023 - 01/2006
11	Dabigatran FDA Link 12/2023 - 11/2013
10	Sodium-Glucose Transport ProteinsIBA 03/2024 - 12/2019
10	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2023 - 12/2019
10	Antihypertensive Agents (Antihypertensives)IBA 07/2022 - 05/2002
10	LDL CholesterolIBA 01/2021 - 08/2002
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2005
9	omega-Chloroacetophenone (Mace)IBA 05/2024 - 07/2015
9	RivaroxabanIBA 12/2023 - 11/2013
9	N(4)-oleylcytosine arabinosideIBA 01/2018 - 07/2015
9	LDL Lipoproteins (beta Lipoproteins)IBA 11/2014 - 12/2005
9	Carvedilol (Coreg)FDA LinkGeneric 05/2009 - 01/2003
8	CarbohydratesIBA 01/2021 - 07/2010
8	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2021 - 06/2006
7	dapagliflozinIBA 01/2023 - 12/2019
7	Hydralazine (Apresoline)FDA LinkGeneric 12/2019 - 02/2009
7	Vasopressins (Vasopressin)IBA 04/2016 - 02/2013

Therapy/Procedure

362	Therapeutics 05/2024 - 01/2002
57	Patient Readmission 02/2024 - 01/2003
52	Length of Stay 12/2023 - 07/2004
48	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 03/2024 - 10/2007
40	Percutaneous Coronary Intervention 12/2023 - 11/2003
34	Cardiac Resynchronization Therapy 03/2024 - 01/2007
28	Secondary Prevention 12/2023 - 06/2003
21	Contraindications 01/2023 - 09/2006
19	Thrombolytic Therapy 01/2023 - 07/2010
11	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2023 - 05/2007
9	Drug Therapy (Chemotherapy) 02/2024 - 08/2002
9	Thrombectomy 10/2023 - 01/2016
8	Cardiac Rehabilitation 01/2023 - 09/2007
7	Defibrillators (Defibrillator) 03/2024 - 11/2014
7	Heart-Assist Devices 11/2023 - 05/2013